Mount Sinai Medical Center — New York, New York

Public research footprint of Mount Sinai Medical Center, compiled from the ClinicalTrials.gov public registry.

861

Registered studies

168

Active

Recruiting now

553

Completed

112

Stopped or withdrawn

Most-studied conditions

Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT07062471 — Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mount Sinai Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.